Researchers find no short-term link between saccharin and development of diabetes New research findings from The Ohio State University Wexner Medical Center found that the artificial sweetener saccharin did not alter the gut microbiota or induce glucose intolerance (an indicator of the development of diabetes) in healthy adults as previous studies have suggested.
The study, published in the journal
Microbiome, was supported by institutional funds from The National Institutes of Health, the National Institute of Food and Agriculture, and Advent-Health.
Saccharin and public health perception
Saccharin (one of the six artificial sweeteners approved by the FDA) is a zero-calorie, high-intensity, artificial sweetener 200 to 700 times sweeter than table sugar (sucrose) and has been used in formulations to sweeten beverages, jams, and baked goods. Its brand names include Sweet and Low, Sweet Twin, Sweet N Low, and Necta Sweet.
Post-Covid Digestive Issues Seen in 30% of Severely Infected Patients by Hannah Joy on January 8, 2021 at 12:37 PM
Around 30 percent of the severely infected covid-19 patients who have come out of the ICU after recovery were found have post-covid digestive issues.
Seniors had severe symptoms like diarrhea, digestive issues, swelling of the liver, low sugar, and pancreas problems, while youngsters may exhibit mild symptoms like diarrhea.
Cough, fever, body ache, neurological symptoms, brain fog, poor appetite, fatigue, and shortness of breath are classic post-covid symptoms that require immediate attention. But, gastrointestinal symptoms like diarrhea, digestive issues, swelling of the liver, low sugar, and pancreas problems are getting missed by the people.
Resolving to Live Healthier? These Juice Delivery Services Make It Easier to Sip Your Greens thetelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thetelegraph.com Daily Mail and Mail on Sunday newspapers.